Howard K. Song MD PhD
Adult Cardiac Surgery, Cardiovascular Surgery
Chief, Division of Cardiothoracic Surgery, Oregon Health & Science University
Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-7820
Fax+1 503-494-7829
Dr. Song is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Thoracic Surgery - Independent, 2004
University of PennsylvaniaPhD, 1997 - 2001
University of Pennsylvania Health SystemResidency, Surgery, 2001- University of Pennsylvania Health SystemInternship, Surgery, 1994 - 1995
Stanford University School of MedicineClass of 1994
Yale UniversityBS, Biology, 1985 - 1989
Certifications & Licensure
WA State Medical License 2010 - 2026
OR State Medical License 2004 - 2025
HI State Medical License Active through 2014
GA State Medical License 2001 - 2005
PA State Medical License 1995 - 2002
American Board of Surgery Surgery
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Portland Monthly Magazine Castle Connolly, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) Start of enrollment: 2013 Oct 01
- 2019-06 TRISCEND Study Start of enrollment: 2020 May 06
Publications & Presentations
PubMed
- 1 citationsMidterm Outcomes: A Comprehensive Approach to Surgery for Hypertrophic Obstructive Cardiomyopathy.Lye-Yeng Wong, Ruben Vila, Gurion Lantz, Julie Doberne, Castigliano M Bhamidipati
The Annals of Thoracic Surgery. 2024-09-01 - 1 citations3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.Firas Zahr, Basel Ramlawi, Michael J Reardon, G Michael Deeb, Steven J Yakubov
JACC. Cardiovascular Interventions. 2024-07-22 - 2 citationsAlternative Access for TAVR: Choosing the Right Pathway.Katherine Lutz, Karla M Asturias, Jasmine Garg, Abhushan Poudyal, Gurion Lantz
Journal of Clinical Medicine. 2024-06-09
Press Mentions
OHSU Resumes Heart Transplant ProgramAugust 26th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
